Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

2018848 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Annals of Oncology

Volume 29, Issue 7, pp. 1541-1547

Field-Weighted Citation Impact: 57.86